SPRI | The Science And Regulations Of Naturally Derived Complex Drugs (2019 EN)

Discussion in 'Medicine' started by Kanka, May 1, 2019.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,086
    Likes Received:
    446
    Trophy Points:
    83
    [​IMG]

    Author: Ram Sasisekharan (Editor), Sau Larry Lee (Editor), Amy Rosenberg (Editor), Larry A. Walker (Editor)
    Full Title: The Science And Regulations Of Naturally Derived Complex Drugs
    Publisher: Springer; 1st ed. 2019 edition (April 24, 2019)
    Year: 2019
    ISBN-13: 9783030117511 (978-3-030-11751-1), 9783030117504 (978-3-030-11750-4)
    ISBN-10: 3030117510, 3030117502
    Pages: 331
    Language: English
    Genre: Biomedical Sciences: Pharmacology
    File type: EPUB (True), PDF (True)
    Quality: 10/10
    Price: 155.99 €


    This volume in the AAPS Advances series covers various quality, safety and clinical aspects of drug development that are relevant to new and/or generic drugs containing a complex mixture of molecules. Specific topics discussed include: raw materials sourcing; manufacturing controls; characterization; identification of critical product quality components and attributes; identification of impurities, particularly as they bear on toxicity and immunogenicity; clinical trial study design considerations, and the regulatory science applications to development of such complex mixtures. Complex mixtures are challenging to characterize and analyze using standard methods. Further challenges extend throughout the product development cycle from raw material control to clinical study design. The regulatory landscape is rapidly changing as new types of complex mixtures are introduced into clinical trials and to the market (e.g., traditional Chinese medicines and medical marijuana products), while older products are facing generic competition for the first time (e.g., enoxaparin). The future outlook for complex generic drug products, as opposed to the more commonly developed targeted single agent drug products is not clear. The risks pertaining to lack of a full understanding of raw material control, process and controls in manufacture, as well as characterization of a complex mixture were seen vividly during the heparin crisis of 2008. As such powerful lessons have been learned about the regulatory science specific to complex products. The Science and Regulations of Naturally Derived Complex Drugs addresses the interests among industry, academics, and government on the issues surrounding the future development of mixtures for medicinal use.

    -------------
     
    Last edited by a moderator: Dec 2, 2019